ALPHA-LIPOIC ACID IN PHARMACEUTICAL DEVELOPMENT: A COMPREHENSIVE REVIEW OF ITS THERAPEUTIC POTENTIAL AND MOLECULAR MECHANISMS
Prospects in Pharmaceutical Sciences · 2025-08-17 · (2025 (Early Access))
DOI: 10.56782/pps.456 ↗At a glance
Journal article in Prospects in Pharmaceutical Sciences, published online on 2025-08-17. Written by Oruç Yunusoğlu and 1 co-authors. Cited 3 times so far (Crossref); 217 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Alpha-lipoic acid (ALA), also known as thioctic acid is a lipid acid with strong biological activity synthesised from octanoic acid in prokaryotic and eukaryotic microorganisms, plants, and animals. It is gaining attention for its potential therapeutic benefits for a wide range of health problems. A comprehensive systematic literature review on ALA has been performed without temporal restrictions utilizing the PubMed, Scopus, Embase, ScienceDirect, SciELO, and SciVerse databases. Different in vitro, in vivo, and clinical studies have demonstrated numerous potent pharmacological activities of ALA, including antioxidant, anti-inflammatory, antimicrobial, anti-Alzheimer, antiepileptic, antiparkinsonian, anxiolytic, effects on schizophrenia, neuroprotective, antidiabetic, antiallergic, anticancer, anti-osteoporosis, cardioprotective, hepatoprotective, anti-obesity, anti-aging, reproductive system, and so on. Although dietary supplements (tablets, capsules, etc.) containing ALA are available due to their various biological activities, there are no Food and Drug Administration (FDA) and European Medicines Agency (EMA)-approved over-the-counter (OTC) ALA drugs in the world. Pharmacokinetically, ALA has an oral bioavailability of approximately 30% due to its brief blood half-life, significant presystemic clearance, and hepatic first-pass metabolism. However, the use of different innovative formulations has greatly enhanced ALA bioavailability. The data obtained show that ALA liquid formulations have higher plasma concentrations and therefore bioavailability compared to solid dosages. These innovative approaches hold promise for the development of improved ALA-based treatments across a broad spectrum of health conditions.
Cite
APA
Yunusoğlu, O., & Koyuncu, E. (2025). ALPHA-LIPOIC ACID IN PHARMACEUTICAL DEVELOPMENT: A COMPREHENSIVE REVIEW OF ITS THERAPEUTIC POTENTIAL AND MOLECULAR MECHANISMS. Prospects in Pharmaceutical Sciences. https://doi.org/10.56782/pps.456
Vancouver
Yunusoğlu O, Koyuncu E. ALPHA-LIPOIC ACID IN PHARMACEUTICAL DEVELOPMENT: A COMPREHENSIVE REVIEW OF ITS THERAPEUTIC POTENTIAL AND MOLECULAR MECHANISMS. Prospects in Pharmaceutical Sciences. 2025. doi:10.56782/pps.456
BibTeX
@article{Yunusolu2025,
author = {Yunusoğlu, Oruç and Koyuncu, Esma},
title = {ALPHA-LIPOIC ACID IN PHARMACEUTICAL DEVELOPMENT: A COMPREHENSIVE REVIEW OF ITS THERAPEUTIC POTENTIAL AND MOLECULAR MECHANISMS},
journal = {Prospects in Pharmaceutical Sciences},
year = {2025},
number = {2025 (Early Access)},
doi = {10.56782/pps.456}
}
EUVIMED